USA: Syngenta seeks approval for GM rice to help kidney patients
US agrochemicals company Syngenta is seeking regulatory approval for a genetically modified rice strain it says will improve the diet of patients undergoing kidney dialysis. The rice strain has been engineered to remove a protein which triggers allergic reactions. It has been designed for the Asian market, where dialysis patients cannot eat the local staple of rice because they suffer intolerance to its high protein content.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Danone's Q1: four things to learn
- Who will buy Danone's Stonyfield business?
- Column: Why snacking is the new meal
- Opinion: Big Food needs to think radically
- US food next wave on display at Winter Fancy Food
- PepsiCo affirms full-year target as Q1 hits mark
- Nestle to cut UK confectionery jobs
- Glanbia signs deal on Dairy Ireland stake sale
- Dole Food Co. files to go public again
- 2 Sisters' chief Boparan invests in UK's Crawshaw